Sun Dagang, Deputy Secretary of the Nanning Municipal Party Committee and Mayor, Visits Baihui Pharmaceutical for Inspection.


Release date:

2021-04-21

On the afternoon of April 20, 2021, Sun Dagang, Deputy Secretary of the Nanning Municipal Party Committee and Mayor, visited Baihui Pharmaceutical for an inspection and research. Huang Zongcheng, Secretary-General of the Municipal Government; Wang Dongming, Director of the Municipal Bureau of Industry and Information Technology; He Shanghan, Director of the Management Committee of the Economic Development Zone, and other colleagues joined the visit.

2021 On the afternoon of April 20, Sun Dagang, Deputy Secretary of the Nanning Municipal Party Committee and Mayor, visited Baihui Pharmaceutical for an inspection and research. Huang Zongcheng, Secretary-General of the Municipal Government; Wang Dongming, Director of the Municipal Bureau of Industry and Information Technology; He Shanghan, Director of the Management Committee of the Economic Development Zone, and other colleagues also joined the visit.

First, He Shanghan reported on the biomedical industry situation in the Economic Development Zone and the park’s development plan for the biomedical sector. Sun Dagang emphasized that we must firmly uphold the new development philosophy, diligently implement the industrial revitalization initiatives, and strengthen coordination and services for enterprises. This will help us further expand and strengthen the biomedical industry, ultimately transforming the Economic Development Zone into a high-tech, nationally and even regionally renowned biomedical cluster with a complete and robust industrial chain in Guangxi and across China.

4

Following this, Sun Dagang visited Baihui Pharmaceutical's historical exhibition hall and production workshop. Guo Xiong, General Manager of Baihui Pharmaceutical, provided a detailed overview of the company's three-year development plan and the current status of its key products' production and operations—particularly highlighting Baihui Pharmaceutical's independent R&D projects for specialized medicines and its strategic industrial layout. Sun Dagang praised Baihui Pharmaceutical's achievements over the past few years, emphasizing that the company should leverage its inherent strengths to further clarify its development positioning and refine its growth strategies. He also urged Baihui Pharmaceutical to continue enhancing, expanding, and strengthening its product portfolio, striving to make an even greater contribution to Guangxi's pharmaceutical industry.